✦ LIBER ✦

Implications of BRCA1 and BRCA2 mutations for the efficacy of paclitaxel monotherapy in advanced ovarian cancer

✍ Scribed by Tan, David S.P.; Yap, Timothy A.; Hutka, Margaret; Roxburgh, Patricia; Ang, Jooern; Banerjee, Susana; Grzybowska, Ewa; Gourley, Charlie; Gore, Martin E.; Kaye, Stan B.

Book ID: 123336879
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 246 KB
Volume: 49
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.11.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

BRCA1- and BRCA2-related mutations: ther

BRCA1- and BRCA2-related mutations: therapeutic implications in ovarian cancer

✍ Pothuri, B. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 121 KB

Contribution of BRCA1 and BRCA2 mutation

Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer

✍ Susan J. Ramus; Patricia A. Harrington; Carole Pye; Richard A. DiCioccio; Mark J 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB

A total of 283 epithelial ovarian cancer families from the United Kingdom (UK) and the United States (US) were screened for coding sequence changes and large genomic alterations (rearrangements and deletions) in the BRCA1 and BRCA2 genes. Deleterious BRCA1 mutations were identified in 104 families (

BRCA1 and BRCA2 gene mutations in heredi

BRCA1 and BRCA2 gene mutations in hereditary and sporadic ovarian cancer and the clinical implications

✍ Samir A. Farghaly 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 129 KB

Ovarian cancer susceptibility alleles an

Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers

✍ Susan J. Ramus; Antonis C. Antoniou; Karoline B. Kuchenbaecker; Penny Soucy; Jon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 1 views

Germline mutations in BRCA1 and BRCA2 are associated with increased risks of breast and ovarian cancer. A genome-wide association study (GWAS) identified six alleles associated with risk of ovarian cancer for women in the general population. We evaluated four of these loci as potential modifiers of

Recurrent BRCA1 and BRCA2 germline mutat

Recurrent BRCA1 and BRCA2 germline mutations in ovarian cancer: A founder mutation of BRCA1 identified in the Chinese population

✍ Ui-Soon Khoo; Kelvin Y.K. Chan; Annie N.Y. Cheung; W.C. Xue; D.H. Shen; K.Y. Fun 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Previous mutational analysis for BRCA gene mutations in sporadic ovarian cancer occurring in Chinese patients in Hong Kong identified six germline BRCA1 mutations and one germline BRCA2 mutation, six of which were novel (Khoo et al., 2000). Knowledge of BRCA gene mutations in the Chinese population

Screening for BRCA1 and BRCA2 mutations

Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families

✍ JM Hartikainen; V Kataja; M Pirskanen; A Arffman; U Ristonmaa; P Vahteristo; M R 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB